{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:16:35Z","timestamp":1790072195813,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Imperial ECMC & NIHR Imperial BRC"},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["737978"],"award-info":[{"award-number":["737978"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Akt signalling regulates glycolysis and drives the Warburg effect in cancer, thus decreased glucose utilisation is a pharmacodynamic marker of Akt inhibition. However, cancer cells can utilise alternative nutrients to glucose for energy such as lactate, which is often elevated in tumours together with increased acidity. We therefore hypothesised that lactic acidosis may confer resistance to Akt inhibition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The effect of the pan-Akt inhibitor uprosertib (GSK2141795), on HCT116 and LS174T colon cancer cells was evaluated in the presence and absence of lactic acid in vitro. Expression of downstream Akt signalling proteins was determined using a phosphokinase array and immunoblotting. Metabolism was assessed using<jats:sup>1<\/jats:sup>H nuclear magnetic resonance spectroscopy, stable isotope labelling and gas chromatography-mass spectrometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Lactic acid-induced resistance to uprosertib was characterised by increased cell survival and reduced apoptosis. Uprosertib treatment reduced Akt signalling and glucose uptake irrespective of lactic acid supplementation. However, incorporation of lactate carbon and enhanced respiration was maintained in the presence of uprosertib and lactic acid. Inhibiting lactate transport or oxidative phosphorylation was sufficient to potentiate apoptosis in the presence of uprosertib.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Lactic acidosis confers resistance to uprosertib, which can be reversed by inhibiting lactate transport or oxidative metabolism.<\/jats:p><\/jats:sec>","DOI":"10.1038\/s41416-020-0777-y","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:03:56Z","timestamp":1583798636000},"page":"1298-1308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells"],"prefix":"10.1038","volume":"122","author":[{"given":"Emily M. E.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Herendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros P.","family":"Siskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric O.","family":"Aboagye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Nijhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7358-8851","authenticated-orcid":false,"given":"Hector C.","family":"Keun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"777_CR1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"777_CR2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J. et al. Metabolic heterogeneity in human lung tumors. Cell 164, 681\u2013694 (2016).","journal-title":"Cell"},{"key":"777_CR3","first-page":"3930","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux, P., V\u00e9gran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N. et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930\u20133942 (2008).","journal-title":"J. Clin. Invest."},{"key":"777_CR4","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1158\/0008-5472.CAN-08-4806","volume":"69","author":"A Hirayama","year":"2009","unstructured":"Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H. et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918\u20134925 (2009).","journal-title":"Cancer Res."},{"key":"777_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs, L. K. & DeBerardinis, R. J. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 17, 351\u2013359 (2015).","journal-title":"Nat. Cell Biol."},{"key":"777_CR6","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1073\/pnas.1307237110","volume":"110","author":"JJ Kamphorst","year":"2013","unstructured":"Kamphorst, J. J., Cross, J. R., Fan, J., Stanchina, E., de, Mathew, R., White, E. P. et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl Acad. Sci. USA 110, 8882\u20138887 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L. et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536, 479\u2013483 (2016).","journal-title":"Nature"},{"key":"777_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","volume":"15","author":"A Le","year":"2012","unstructured":"Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J. et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110\u2013121 (2012).","journal-title":"Cell Metab."},{"key":"777_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cmet.2018.07.005","volume":"28","author":"M Tajan","year":"2018","unstructured":"Tajan, M., Hock, A. K., Blagih, J., Robertson, N. A., Labuschagne, C. F., Kruiswijk, F. et al. A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3. Cell Metab. 28, 721\u2013736.e6 (2018).","journal-title":"Cell Metab."},{"key":"777_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123, 309\u2013314 (1956).","journal-title":"Science"},{"key":"777_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","volume":"14","author":"S Walenta","year":"2004","unstructured":"Walenta, S. & Mueller-Klieser, W. F. Lactate: mirror and motor of tumor malignancy. Semin Radiat. Oncol. 14, 267\u2013274 (2004).","journal-title":"Semin Radiat. Oncol."},{"key":"777_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","volume":"343","author":"AP Halestrap","year":"1999","unstructured":"Halestrap, A. P. & Price, N. T. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343, 281\u2013299 (1999).","journal-title":"Biochem. J."},{"key":"777_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","volume":"64","author":"AP Halestrap","year":"2012","unstructured":"Halestrap, A. P. The monocarboxylate transporter family\u2013Structure and functional characterization. IUBMB Life 64, 1\u20139 (2012).","journal-title":"IUBMB Life"},{"key":"777_CR14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.CAN-11-2474","volume":"72","author":"R Boidot","year":"2012","unstructured":"Boidot, R., V\u00e9gran, F., Meulle, A., Le Breton, A., Dessy, C., Sonveaux, P. et al. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res. 72, 939\u2013948 (2012).","journal-title":"Cancer Res."},{"key":"777_CR15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert, B., Li, K. Y., Cai, L., Hensley, C. T., Kim, J., Zacharias, L. G. et al. Lactate metabolism in human lung tumors. Cell 171, 358\u2013371.e9 (2017).","journal-title":"Cell"},{"key":"777_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui, S., Ghergurovich, J. M., Morscher, R. J., Jang, C., Teng, X., Lu, W. et al. Glucose feeds the TCA cycle via circulating lactate. Nature 551, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"777_CR17","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","volume":"64","author":"RL Elstrom","year":"2004","unstructured":"Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R. et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64, 3892\u20133899 (2004).","journal-title":"Cancer Res."},{"key":"777_CR18","first-page":"33","volume":"7","author":"DH Josephs","year":"2015","unstructured":"Josephs, D. H. & Sarker, D. Pharmacodynamic biomarker development for PI3K pathway therapeutics. Transl. Oncogenomics 7, 33\u201349 (2015).","journal-title":"Transl. Oncogenomics"},{"key":"777_CR19","doi-asserted-by":"crossref","first-page":"41736","DOI":"10.18632\/oncotarget.6153","volume":"6","author":"A Cheraghchi-Bashi","year":"2015","unstructured":"Cheraghchi-Bashi, A., Parker, C. A., Curry, E., Salazar, J.-F., Gungor, H., Saleem, A. et al. A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway. Oncotarget 6, 41736\u201341749 (2015).","journal-title":"Oncotarget"},{"key":"777_CR20","doi-asserted-by":"crossref","first-page":"e100880","DOI":"10.1371\/journal.pone.0100880","volume":"9","author":"M Dumble","year":"2014","unstructured":"Dumble, M., Crouthamel, M.-C., Zhang, S.-Y., Schaber, M., Levy, D., Robell, K. et al. Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor. PLoS ONE 9, e100880 (2014).","journal-title":"PLoS ONE"},{"key":"777_CR21","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1021\/pr400455j","volume":"12","author":"F Pachl","year":"2013","unstructured":"Pachl, F., Plattner, P., Ruprecht, B., M\u00e9dard, G., Sewald, N. & Kuster, B. Characterization of a chemical affinity probe targeting Akt kinases. J. Proteome Res. 12, 3792\u20133800 (2013).","journal-title":"J. Proteome Res."},{"key":"777_CR22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s10637-018-0591-z","volume":"36","author":"C Aghajanian","year":"2018","unstructured":"Aghajanian, C., Bell-McGuinn, K. M., Burris, H. A., Siu, L. L., Stayner, L.-A., Wheler, J. J. et al. A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors. Invest. N. Drugs 36, 1016\u20131025 (2018).","journal-title":"Invest. N. Drugs"},{"key":"777_CR23","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2967\/jnumed.115.156505","volume":"56","author":"H Gungor","year":"2015","unstructured":"Gungor, H., Saleem, A., Babar, S., Dina, R., El-Bahrawy, M. A., Curry, E. et al. Dose-finding quantitative 18F-FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecologic malignancies. J. Nucl. Med. Publ. Soc. Nucl. Med. 56, 1828\u20131835 (2015).","journal-title":"J. Nucl. Med. Publ. Soc. Nucl. Med."},{"key":"777_CR24","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.1106123108","volume":"108","author":"R Le Floch","year":"2011","unstructured":"Le Floch, R., Chiche, J., Marchiq, I., Naiken, T., Na\u00efken, T., Ilc, K. et al. CD147 subunit of lactate\/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc. Natl Acad. Sci. USA 108, 16663\u201316668 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D. et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl Cancer Inst. 82, 1107\u20131112 (1990).","journal-title":"J. Natl Cancer Inst."},{"key":"777_CR26","volume":"7","author":"C-HE Lau","year":"2017","unstructured":"Lau, C.-H. E., Tredwell, G. D., Ellis, J. K., Lam, E. W.-F. & Keun, H. C. Metabolomic characterisation of the effects of oncogenic PIK3CA transformation in a breast epithelial cell line. Sci. Rep. 7, 46079 (2017).","journal-title":"Sci. Rep."},{"key":"777_CR27","unstructured":"Siderius D. NIST Standard Reference Simulation Website. (National Institute of Standards and Technology, 2006). https:\/\/www.nist.gov\/programs-projects\/nist-standard-reference-simulation-website."},{"key":"777_CR28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ab.2011.04.009","volume":"415","author":"V Behrends","year":"2011","unstructured":"Behrends, V., Tredwell, G. D. & Bundy, J. G. A software complement to AMDIS for processing GC-MS metabolomic data. Anal. Biochem. 415, 206\u2013208 (2011).","journal-title":"Anal. Biochem."},{"key":"777_CR29","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7007-10-29","volume":"10","author":"M Vinci","year":"2012","unstructured":"Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W. et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 10, 29 (2012).","journal-title":"BMC Biol."},{"key":"777_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/15384101.2015.1120930","volume":"15","author":"J P\u00e9rez-Escuredo","year":"2015","unstructured":"P\u00e9rez-Escuredo, J., Dadhich, R. K., Dhup, S., Cacace, A., Van H\u00e9e, V. F., De Saedeleer, C. J. et al. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 15, 72\u201383 (2015).","journal-title":"Cell Cycle"},{"key":"777_CR31","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1074\/jbc.RA119.007841","volume":"294","author":"M Ying","year":"2019","unstructured":"Ying, M., Guo, C. & Hu, X. The quantitative relationship between isotopic and net contributions of lactate and glucose to the TCA cycle. J. Biol. Chem. 294, 9615\u20139630 (2019).","journal-title":"J. Biol. Chem."},{"key":"777_CR32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir, M. Y., Nogueira, V., Fontaine, E., Av\u00e9ret, N., Rigoulet, M. & Leverve, X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275, 223\u2013228 (2000).","journal-title":"J. Biol. Chem."},{"key":"777_CR33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607\u2013614 (2000).","journal-title":"Biochem. J."},{"key":"777_CR34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/cts.12551","volume":"11","author":"P Fisel","year":"2018","unstructured":"Fisel, P., Schaeffeler, E. & Schwab, M. Clinical and functional relevance of the monocarboxylate transporter family in disease pathophysiology and drug therapy. Clin. Transl. Sci. 11, 352\u2013364 (2018).","journal-title":"Clin. Transl. Sci."},{"key":"777_CR35","volume":"11","author":"N Gupta","year":"2018","unstructured":"Gupta, N., Duggal, S., Kumar, A., Saquib, N. M. & Rao, K. V. S. Concurrent interactome and metabolome analysis reveals role of AKT1 in central carbon metabolism. BMC Res. Notes 11, 270 (2018).","journal-title":"BMC Res. Notes"},{"key":"777_CR36","first-page":"1","volume":"8","author":"DA Kane","year":"2014","unstructured":"Kane, D. A. Lactate oxidation at the mitochondria: a lactate-malate-aspartate shuttle at work. Front Neurosci. 8, 1\u20136 (2014).","journal-title":"Front Neurosci."},{"key":"777_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cmet.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks, G. A. The science and translation of lactate shuttle theory. Cell Metab. 27, 57\u201385 (2018).","journal-title":"Cell Metab."},{"key":"777_CR38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nchembio.2172","volume":"12","author":"Y-J Chen","year":"2016","unstructured":"Chen, Y.-J., Mahieu, N. G., Huang, X., Singh, M., Crawford, P. A., Johnson, S. L. et al. Lactate metabolism is associated with mammalian mitochondria. Nat. Chem. Biol. 12, 937\u2013943 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"777_CR39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.celrep.2016.03.026","volume":"15","author":"S Park","year":"2016","unstructured":"Park, S., Chang, C., Safi, R., Liu, X., Baldi, R., Jasper, J. S. et al. ERR\u03b1 regulated lactate metabolism contributes to resistance to targeted therapies in breast cancer. Cell Rep. 15, 323 (2016).","journal-title":"Cell Rep."},{"key":"777_CR40","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-14-2290","volume":"21","author":"TT Vellinga","year":"2015","unstructured":"Vellinga, T. T., Borovski, T., de Boer, V. C. J., Fatrai, S., van Schelven, S., Trumpi, K. et al. SIRT1\/PGC1\u03b1-dependent increase in oxidative phosphorylation supports chemotherapy resistance of colon cancer. Clin. Cancer Res. 21, 2870\u20132879 (2015).","journal-title":"Clin. Cancer Res."},{"key":"777_CR41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","volume":"514","author":"A Viale","year":"2014","unstructured":"Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., S\u00e1nchez, N., Marchesini, M. et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514, 628\u2013632 (2014).","journal-title":"Nature"},{"key":"777_CR42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","volume":"23","author":"R Haq","year":"2013","unstructured":"Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G. C. et al. Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF. Cancer Cell 23, 302\u2013315 (2013).","journal-title":"Cancer Cell"},{"key":"777_CR43","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1182\/blood.V128.22.4526.4526","volume":"128","author":"S Trudel","year":"2016","unstructured":"Trudel, S., Bahlis, N. J., Venner, C. P., Hay, A. E., Kis, O., Chow, S. et al. Biomarker driven phase II clinical trial of trametinib in relapsed\/refractory multiple myeloma with sequential addition of the AKT inhibitor, GSK2141795 at time of disease progression to overcome treatment failure. Blood 128, 4526 (2016).","journal-title":"Blood"},{"key":"777_CR44","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1200\/JCO.2016.34.15_suppl.9511","volume":"34","author":"AN Shoushtari","year":"2016","unstructured":"Shoushtari, A. N., Kudchadkar, R. R., Panageas, K., Murthy, R. K., Jung, M., Shah, R. et al. A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma. J. Clin. Oncol. 34, 9511\u20139511 (2016).","journal-title":"J. Clin. Oncol."},{"key":"777_CR45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/pcmr.12644","volume":"31","author":"AP Algazi","year":"2018","unstructured":"Algazi, A. P., Esteve\u2010Puig, R., Nosrati, A., Hinds, B., Hobbs\u2010Muthukumar, A., Nandoskar, P. et al. Dual MEK\/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma. Pigment Cell Melanoma Res. 31, 110\u2013114 (2018).","journal-title":"Pigment Cell Melanoma Res."},{"key":"777_CR46","first-page":"95","volume":"154","author":"JF Liu","year":"2019","unstructured":"Liu, J. F., Gray, K. P., Wright, A. A., Campos, S., Konstantinopoulos, P. A., Peralta, A. et al. Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer. Gynecol. Oncol. 154, 95\u2013101 (2019).","journal-title":"Gynecol. Oncol."},{"key":"777_CR47","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/leu.2013.107","volume":"27","author":"S Scotland","year":"2013","unstructured":"Scotland, S., Saland, E., Skuli, N., de Toni, F., Boutzen, H., Micklow, E. et al. Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells. Leukemia 27, 2129\u20132138 (2013).","journal-title":"Leukemia"},{"key":"777_CR48","doi-asserted-by":"crossref","first-page":"C761","DOI":"10.1152\/ajpcell.1993.264.4.C761","volume":"264","author":"RC Poole","year":"1993","unstructured":"Poole, R. C. & Halestrap, A. P. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol.-Cell Physiol. 264, C761\u2013C782 (1993).","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"777_CR49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00424-003-1067-2","volume":"447","author":"AP Halestrap","year":"2004","unstructured":"Halestrap, A. P. & Meredith, D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pfl\u00fcgers Arch. 447, 619\u2013628 (2004).","journal-title":"Pfl\u00fcgers Arch."},{"key":"777_CR50","volume":"4","author":"J Xie","year":"2014","unstructured":"Xie, J., Wu, H., Dai, C., Pan, Q., Ding, Z., Hu, D. et al. Beyond Warburg effect \u2013 dual metabolic nature of cancer cells. Sci. Rep. 4, 4927 (2014).","journal-title":"Sci. Rep."},{"key":"777_CR51","doi-asserted-by":"crossref","first-page":"24415","DOI":"10.18632\/oncotarget.14705","volume":"8","author":"VF Van H\u00e9e","year":"2017","unstructured":"Van H\u00e9e, V. F., Labar, D., Dehon, G., Grasso, D., Gr\u00e9goire, V., Muccioli, G. G. et al. Radiosynthesis and validation of (\u00b1)-[18F]-3-fluoro-2-hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors. Oncotarget 8, 24415\u201324428 (2017).","journal-title":"Oncotarget"},{"key":"777_CR52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-018-0279-5","volume":"21","author":"X Guan","year":"2019","unstructured":"Guan, X., Rodriguez-Cruz, V. & Morris, M. E. Cellular uptake of MCT1 inhibitors AR-C155858 and AZD3965 and their effects on MCT-mediated transport of L-Lactate in murine 4T1 breast tumor cancer cells. AAPS J. 21, 13 (2019).","journal-title":"AAPS J."},{"key":"777_CR53","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3324\/haematol.2016.163030","volume":"102","author":"RA Noble","year":"2017","unstructured":"Noble, R. A., Bell, N., Blair, H., Sikka, A., Thomas, H., Phillips, N. et al. Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma. Haematologica 102, 1247\u20131257 (2017).","journal-title":"Haematologica"},{"key":"777_CR54","doi-asserted-by":"crossref","unstructured":"Liu C., Wu J., Zhu J., Kuei C., Yu J., Shelton J., et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J. Biol. Chem. 284, 2811\u20132822.","DOI":"10.1074\/jbc.M806409200"},{"key":"777_CR55","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-14-0319","volume":"74","author":"CL Roland","year":"2014","unstructured":"Roland, C. L., Arumugam, T., Deng, D., Liu, S. H., Philip, B., Gomez, S. et al. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 74, 5301\u20135310 (2014).","journal-title":"Cancer Res."},{"key":"777_CR56","doi-asserted-by":"crossref","first-page":"70898","DOI":"10.18632\/oncotarget.12286","volume":"7","author":"YJ Lee","year":"2016","unstructured":"Lee, Y. J., Shin, K. J., Park, S.-A., Park, K. S., Park, S., Heo, K. et al. G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion. Oncotarget 7, 70898\u201370911 (2016).","journal-title":"Oncotarget"},{"key":"777_CR57","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3892\/or.2014.3655","volume":"33","author":"C Huang","year":"2014","unstructured":"Huang, C., Sheng, S., Li, R., Sun, X., Liu, J. & Huang, G. Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation. Oncol. Rep. 33, 875\u2013884 (2014).","journal-title":"Oncol. Rep."},{"key":"777_CR58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccell.2016.08.005","volume":"30","author":"L Brisson","year":"2016","unstructured":"Brisson, L., Ba\u0144ski, P., Sboarina, M., Dethier, C., Danhier, P., Fontenille, M.-J. et al. Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell 30, 418\u2013431 (2016).","journal-title":"Cancer Cell"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0777-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:44Z","timestamp":1684616864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-0777-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,4,28]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-0777-y","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No human or animal ethics approval was required for this study. The LS174T cells were received as a generous gift from Prof. Jacques Pouyss\u00e9gur at the University of Nice, Nice, France. The HCT116 cells were received as a generous gift from Dr Volker Arlt at King\u2019s College London, London, United Kingdom.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Data generated for the current study are available from the corresponding author on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was funded by Cancer Research UK Imperial Centre at Imperial College London (C17375\/ A19482) and by MetaCell-TM H2020 Fast Track to Innovation (737978). A.P.S. was funded by Imperial Experimental Cancer Medicine Centre & National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}